DaShenLin Pharmaceutical Group Co Stock

DaShenLin Pharmaceutical Group Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of DaShenLin Pharmaceutical Group Co (603233.SS) as of Aug 15, 2026 is 13.39. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 15.86 — a change of -15.53% (lower).

P/FCF

13.39

YoY

-15.53%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of DaShenLin Pharmaceutical Group Co is 2026 13.39 . P/FCF (Price-to-Free-Cash-Flow Ratio) of DaShenLin Pharmaceutical Group Co was 2025 15.86 . It decreases by -15.53% lower compared to the previous year.
Access this data via the Eulerpool API

DaShenLin Pharmaceutical Group Co Stock analysis

What does DaShenLin Pharmaceutical Group Co do? DaShenLin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DaShenLin Pharmaceutical Group Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of DaShenLin Pharmaceutical Group Co is 13.39 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of DaShenLin Pharmaceutical Group Co changed from 15.86 to 13.39, representing a -15.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) DaShenLin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s DaShenLin Pharmaceutical Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — DaShenLin Pharmaceutical Group Co

All Key Metrics — DaShenLin Pharmaceutical Group Co